From gene cloning and initial clone selection through to final cell evaluation, the continual assessment of cell count and viability is important for determining the best growing and highest producing ...

This article is based on a poster originally authored by Julia Scherzinger, Daniel Türk, and Fernando Aprile-Garcia from CYTENA GmbH. There is constant pressure to reduce timelines in mammalian cell ...

Cell line creation is a major success factor in biologics manufacturing. It establishes the basis for product yield, quality, and long-term process stability. However, despite significant ...

Cell line development continues to face technical and operational hurdles in transfection, clone selection, and media optimization. Manual screening, extended culture timelines, and fragmented data ...

Choosing the right cell line is a critical part of biopharmaceutical process development. Getting it wrong can delay scaleup and hurt a drug’s commercial potential. The key to success is full ...

U.S. government researchers have made a significant step forward in developing a fully automated process for cell-line development. The National Institute of Allergy and Infectious Diseases (NIAID), ...

New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications ...